Editas Medicine
EDIT • NASDAQ
Editas Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gilmore O'Neill, with a market cap of $218.3M.
Market Cap$218.3M
Employees226.0
CEOGilmore O'Neill
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Editas Medicine FAQ
Common questions about Editas Medicine
Editas Medicine is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $5.9M.
Editas Medicine has approximately 226 employees.